Aligos Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
ALGS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
One Corporate Dr., 2 Nd Floor, South San Francisco, CA

Insiders trading volume in the past year

Aligos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Carole Nuechterlein Director $8.34M +$6M +257% Jun 27, 2024
Lawrence Blatt Chief Executive Officer, Director $1.41M Sep 4, 2024
James Scopa Director $139K Jun 27, 2024
Lesley Ann Calhoun Chief Financial Officer Sep 4, 2024
Matthew W. McClure Chief Medical Officer Mar 1, 2024
Roche Holding Ltd 10%+ Owner Oct 25, 2023
Jack Nielsen Director Feb 27, 2024
Bridget Martell Director Jun 27, 2024
Leonid Beigelman President, Director Mar 15, 2023
Lucinda Y. Quan Executive Vice President, Chief Business Officer and General Counsel Sep 8, 2023
Julian A. Symons Executive Vice President, Chief Scientific Officer Sep 4, 2024
Heather Preston Director Aug 7, 2024
Thomas Woiwode Director Jun 23, 2022
Margarita Chavez Director Aug 7, 2024
Peter Hirth Director Jun 27, 2024

Recent Insider Transactions by Companies or Individuals for Aligos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.